NCT06883487View on ClinicalTrials.gov

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

RecruitingOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

April 7, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian CancerObserving the Effectiveness of Targeted HER2 ADC Drugs
Interventions
OTHER

No intervention

Observational study without intervention

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER